VITA325 Company Profile

Background

Overview

VITA325 is a Ukrainian healthtech startup founded in 2024, specializing in digital rehabilitation solutions for individuals with lower-limb amputations. The company has developed an AI-powered mobile platform that transforms smartphones into intelligent rehabilitation tools, aiming to enhance recovery processes and improve mobility for prosthetic users.

Mission and Vision

VITA325's mission is to empower individuals facing life after trauma with solutions that fit into their reality, helping them move forward, feel supported, and live fully again. Their vision is to reimagine recovery to be personal, accessible, and with patients every step of the way—not just in hospitals, but at home, in motion, and in real time.

Primary Area of Focus

The company's primary focus is on providing innovative rehabilitation solutions for lower-limb prosthetic users, utilizing smartphone technology to deliver real-time gait diagnostics, personalized physiotherapy plans, and remote monitoring without the need for additional wearables or expensive equipment.

Industry Significance

VITA325 addresses a significant gap in the rehabilitation sector by offering accessible and scalable solutions for prosthetic users, potentially transforming recovery processes and improving quality of life for individuals worldwide.

Key Strategic Focus

Core Objectives

Accessibility: Making rehabilitation tools accessible through smartphones, eliminating the need for specialized equipment.

Personalization: Providing personalized physiotherapy plans tailored to individual needs.

Remote Monitoring: Enabling clinicians to monitor patient progress remotely, enhancing care efficiency.

Specific Areas of Specialization

Gait Analysis: Utilizing AI and computer vision to analyze walking patterns and gait asymmetry.

Motion Diagnostics: Assessing joint mobility, posture, and movement metrics.

Rehabilitation Support: Offering real-time feedback and automated reporting to support recovery.

Key Technologies Utilized

Artificial Intelligence (AI): For motion analysis and personalized physiotherapy plan development.

Computer Vision: To interpret movement data from smartphone sensors.

Mobile Application Development: Creating user-friendly interfaces for seamless user experience.

Primary Markets Targeted

Individuals with Lower-Limb Amputations: Focusing on those using prosthetics and undergoing rehabilitation.

Clinics and Rehabilitation Centers: Providing tools for remote patient monitoring and progress tracking.

Healthcare Systems: Aiming to reduce costs and improve rehabilitation outcomes.

Financials and Funding

Funding History

VITA325 has secured funding through various channels, including grants and accelerator programs. In August 2025, the company received a grant from the Ukrainian Startup Fund, amounting to $50,000, to support its product development and market expansion efforts.

Total Funds Raised

The total funds raised by VITA325 are not publicly disclosed.

Notable Investors

Ukrainian Startup Fund: Provided a grant in August 2025.

Intended Utilization of Capital

The capital is intended to support ongoing product development, enhance the capabilities of the mobile platform, and facilitate the company’s plans for growth initiatives, including potential expansion into new markets and strengthening its operational framework.

Pipeline Development

Key Pipeline Candidates

VITA325 is focusing on developing its AI-powered mobile rehabilitation platform, with an emphasis on:

Gait Analysis Tools: Enhancing the accuracy and real-time capabilities of gait diagnostics.

Personalized Physiotherapy Plans: Improving the customization and effectiveness of rehabilitation exercises.

Remote Monitoring Features: Expanding clinician access to patient progress and data-driven insights.

Stages of Development

Prototype Testing: Conducted initial testing demonstrating the effectiveness and accuracy of the results.

Clinical Trials: Plans to perform clinical trials in Ukraine to validate the platform's efficacy.

Target Conditions

Lower-Limb Amputations: Focusing on rehabilitation for individuals with below-knee or above-knee amputations.

Anticipated Milestones

Clinical Validation: Completion of clinical trials to validate the platform's effectiveness.

Market Expansion: Scaling the platform to reach a broader user base, including international markets.

Technological Platform and Innovation

Proprietary Technologies

AI-Powered Motion Analysis: For precise gait tracking and personalized rehabilitation plans.

Computer Vision Algorithms: To interpret movement data from smartphone sensors.

Significant Scientific Methods

Gait Function Testing: Utilizing standardized clinical walking tests integrated into the mobile platform.

Automated Reporting: Generating real-time progress reports for clinicians and patients.

Leadership Team

Key Executives

Yuliia Koinak: Co-Founder & CEO. An award-winning founder with over 15 years in global business and venture building, known for fast execution and scaling in deeptech and health innovation.

Danylo Intelehator: Clinical Lead (CPO, OT). A certified occupational therapist, prosthetist, and rehab instructor with over 7 years in neuro and mobility recovery.

Anna Batii: COO. An operations leader with over 8 years in tech project management, experienced in international team coordination, partnerships, and startup scaling.

Dmytro Karavelkov: CTO. An ML engineer specializing in motion diagnostics and computer vision for mobile rehab.

Mike Tymoshenko: CFO. A finance executive with over 10 years in startup and finance, expert in budgeting, investment, financial strategy, and managing international grant programs.

Serhii Penzev: Marketing Executive. A digital growth specialist with over 8 years in marketing, experienced in SEO, lead generation, user acquisition, analytics, and sales funnel optimization.

Oleh Kvachov: Senior Project Manager. A professional with over 6 years in software development, product management, and leading cross-functional teams to deliver scalable, user-centric solutions.

Leadership Changes

No significant leadership changes have been reported.

Competitor Profile

Market Insights and Dynamics

The rehabilitation technology market is experiencing growth, driven by advancements in AI and mobile health solutions. There is an increasing demand for accessible and cost-effective rehabilitation tools, especially for individuals with mobility challenges.

Competitor Analysis

OneStep: Offers a smartphone-based gait analysis app for individuals with lower-limb amputations.

Moticon Science: Provides wearable devices for gait analysis and rehabilitation.

Shirley Ryan AbilityLab: A clinical lab offering comprehensive rehabilitation services, including gait analysis.

Strategic Collaborations and Partnerships

VITA325 has been selected for various accelerator programs and partnerships, including:

Seeds of Bravery: A €20 million project funded by the European Union under the European Innovation Council (EIC) to support Ukrainian tech startups.

EIT Health Women Entrepreneurship Bootcamp 2025: A program designed to accelerate promising women-driven health innovations across Europe.

Operational Insights

VITA325 differentiates itself by offering a smartphone-based solution that eliminates the need for additional wearables or specialized equipment, making rehabilitation more accessible and cost-effective. The company's focus on AI and computer vision enables precise gait analysis and personalized rehabilitation plans, enhancing recovery outcomes.

Strategic Opportunities and Future Directions

VITA325 aims to expand its platform to serve a broader range of mobility challenges, including neurological disorders and other conditions affecting movement. The company plans to scale accordingly.

vita325